U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
REGN-5069
Preferred Name English
NADECNEMAB
INN  
Official Name English
nadecnemab [INN]
Common Name English
REGN5069
Code English
IMMUNOGLOBULIN G4 (232-PROLINE), ANTI-(HUMAN GLIAL CELL-DERIVED NEUROTROPHIC FACTOR RECEPTOR .ALPHA.3) (HUMAN MONOCLONAL REGN5069 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN5069 .KAPPA.-CHAIN, DIMER
Common Name English
Code System Code Type Description
FDA UNII
1AIQ625714
Created by admin on Wed Apr 02 02:36:13 GMT 2025 , Edited by admin on Wed Apr 02 02:36:13 GMT 2025
PRIMARY
SMS_ID
300000032302
Created by admin on Wed Apr 02 02:36:13 GMT 2025 , Edited by admin on Wed Apr 02 02:36:13 GMT 2025
PRIMARY
NCI_THESAURUS
C179104
Created by admin on Wed Apr 02 02:36:13 GMT 2025 , Edited by admin on Wed Apr 02 02:36:13 GMT 2025
PRIMARY
INN
11567
Created by admin on Wed Apr 02 02:36:13 GMT 2025 , Edited by admin on Wed Apr 02 02:36:13 GMT 2025
PRIMARY INN
CAS
2377679-19-9
Created by admin on Wed Apr 02 02:36:13 GMT 2025 , Edited by admin on Wed Apr 02 02:36:13 GMT 2025
PRIMARY
ACTIVE MOIETY
NADECNEMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966